Difference between revisions of "CT Volumetry Biomarker Ctte"

Revision as of 14:19, 21 July 2022

Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD

RSNA Staff Support: Julie Lisiecki

Meetings

Tcons are held periodically. Contact RSNA Staff for details.

Recent Call Summaries:

CT Volumetry BC Call Summaries Archive

Profile Development

Streamlined Profile (also on Profile page)

CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile

32 pages including Conformance Checklists

Status - Balloting Streamlined Profile

CT Tumor Volume Change Profile - Streamlined Draft 2022.03.03
CT Tumor Volume Change Profile - Streamlined Draft 2021.12.09

The Technically Confirmed Profile is on the Profiles page.

Stage 4 Planning

Draft Stage 4 Plan - Google Doc

Past and Future

Archived Versions of Profile-related documents.
Considerations for Future Editions of CTV-AD

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

NIBIB-2 Proposal for CT Volumetry16-APR-2012

Reference Materials

2012

Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
- ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.
"Why QIBA?" - Specifics associated with CT device and software manufacturers.

2011

Dr Petrick's 2011 SPIE Presentation Materials
“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk
“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper
Compliance Documents: QIBA Approach to Compliance-- Andrew J. Buckler, MS, Program Director, QIBA 08.15.11

2010

Quantification in Imaging-Dr Dirk Colditz August 23, 2010
Project plan .jpg version as of 11-8-10

Reference Articles

Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

Archive - Initial Target Selection and Roadmap

QIBA Funded Projects

Round 1

Round 2

Round 3

Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)

Round 4

Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)

Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)

Round 5

Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)

Round 6

Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)

@@ Line 1: / Line 1: @@
-==Project Snapshot==
+{{TOCright}}
-*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
+:Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD
+:RSNA Staff Support: Julie Lisiecki
+* [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
+* [https://docs.google.com/spreadsheets/d/1qbBHaJNTAqHnAcmCTHsNfDph7hMyJ3NoUjYSdilVw8w/edit#gid=267283460 Attendance & Voting Privileges]
-*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
+==Meetings==
-*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
+* Tcons are held periodically. Contact RSNA Staff for details.
-'''[[:Category:Datasets| See the Datasets page]]''' of the [[Catalog|QIBA Resource Catalog]]
-==Meetings / Call Summaries==
-*[[Call Summaries]]
-==Profile Development==
+'''Recent Call Summaries:'''
+*[[Media:06 29 2022 QIBA CT Volumetry BC Call-FINAL.pdf|06.29.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:05 26 2022 QIBA CT Volumetry BC Call-FINAL.pdf|05.26.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:04 20 2022 QIBA CT Volumetry BC Call-FINAL.pdf|04.20.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:03 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|03.15.2022 QIBA CT Volumetry BC Call Summary]]
+*[[Media:02 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|02.15.2022 QIBA CT Volumetry BC Call Summary]]
-===Advanced Disease Profile===
-Status - Now Resolving Public Comment
-*[[Media:QIBA Vol-CT AdvDiseaseV2 1 Profile Draft 05MAR2012.doc|QIBA Vol-CT AdvDiseaseV2.1 Profile draft 2012-03-05]] ''(Current Profile Draft) 2012-03-05''
+'''''[[CT Volumetry BC Call Summaries Archive]]'''''
-*[[Media:QIBA Vol-CT AdvDiseaseV2 0 Public Comment Resolution 05MAR2012.doc|QIBA Vol-CT AdvDiseaseV2.0 Public Comment Resolution 2012-03-05]] ''(Public Comment & Resolution) 2012-03-05''
+==Profile Development==
+'''Streamlined Profile (also on Profile page)'''
+* [[Media:QIBACTVol_TumorVolumeChange(2022)-20220721.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile]]
+:* 32 pages including Conformance Checklists
+'''Status - Balloting Streamlined Profile'''
+*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20220303.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2022.03.03
+*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20211209.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
-*[[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|Advanced Disease Profile V2 0f.pdf]] ''(Original Public Comment Draft) 2011-07-28''
+The Technically Confirmed Profile is on the [[Profiles]] page.
+'''Stage 4 Planning'''
+:* [https://docs.google.com/document/d/1Wcmkzp8N_2lLL-FCykNPwgsn1BJOs7Z9A1ZyTIkuGCo/edit?usp=sharing Draft Stage 4 Plan - Google Doc]
+'''Past and Future'''
-[[Archived Versions]] of QIBA draft documents.
+:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
+:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
 ==Groundwork Projects==
 These projects investigate (and resolve) scientific questions underlying QIBA Profile work.
+* [[VolCT - Group 1A]] - Analyze Bias/Variance where Ground Truth is Known Deterministically
 * [[VolCT - Group 1B]] - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
 * [[VolCT - Group 1C]] - Model Sources of Variability from a Systems Engineering Analysis
-* [[VolCT - Group 3A]] - Characterize variability due to algorithm using phantoms
+* [[VolCT - Group 3A]] - Characterize variability due to algorithms (using phantoms / clinical data)
 * [[VolCT - Group 3B]] - Characterize clinical utility/efficacy with respect to clinical endpoints
 * [[VolCT - Colorado Group]] - Quantifying variability in measurement of pulmonary nodule
-==Working Documents==
+*[[Media:NIBIB-2 Proposal for CT Volumetry 16APR2012.pdf|NIBIB-2 Proposal for CT Volumetry]]''16-APR-2012''
-<<We should tidy up this section and archive or label accordingly>>
-No longer active:
+==Reference Materials==
-*Advanced Disease:
-** [[Media:2011.02.28.Profile CT advanced disease V1 6.doc|VIA Profile v1.6]] ''02/28/2011''
-** [[Media:2011.01.09.QIBA VIA Profile V1 5.doc|VIA Profile v1.5]] ''01/09/2011''
-*[[Media: 2010.09.09.UPICT_CT_Lung_Nodule_V1_4a.cleaner copy.doc|VIA Protocol v1.4]] ''Word version known as field test v1.0, 09-09-2010''
-*[[Media: 2010.09.09_UPICT_V1_4_1_FIELD_TEST.doc|VIA Protocol v1.4.1]] ''(Early field test protocol draft) 2010-09-09''
-*Small Nodule:
+'''2012'''
-** [[Media:2011.03.12 Profile CT small nodule V0 6.doc|Small Pulmonary Nodule Profile v0.6]] ''03/12/2011''
+*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
-** [[Media:2011.02.14 Profile CT early disease V0 4.doc|Small Pulmonary Nodule Profile v0.4]] ''02/14/2011''
+**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
-* [http://docs.google.com/Doc?docid=0ASSwlnzdbPEGZHJyc2pxcF8zcHFkdnhqY3A&hl=en| UPICT Template for CT Lung Nodule Protocol] ''Google doc version of v1.4 WIP''
+*[[Media:Why QIBA CT specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
-*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
-*[[Media:Work breakdown for volCT-formatted.doc| Work Breakdown for Volumetric CT]] ''07.12.10''
-* [[VolCT - Group 1A]] - Analyze Bias/Variance where Ground Truth is Known Deterministically
-*[[Media:2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors.long version.doc|2009 12 31 Review of Volumetric Image Analysis in Patients with Solid Tumors - long version]]
-*[[Media: QIBA_Vol-CT_Profile_v1.1-ABuckler-20090903.doc|VIA Profile v1.1]] ''Word version 09-03-2009''
-* [[Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites]] ''Last updated 6/2009''
-* [[Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting]] ''Last updated 6/2009''
-*[[Media:2008.09.15.Validation_Roadmap_VOL-CT_Image_Analysis.pdf|Validation Roadmap - P. David Mozley, MD]]
-*[[Media:Mr ODonnell QIBA Process Roadmap 20090629.ppt.pdf|Thoughts on the QIBA Process: Profiles, UPICT & Measurements by Kevin O’Donnell-20090629]]
-* [[VolCT - Group 2]] - Set Standards for using Volumetric Imaging in Clinical Trials
-* [[Profile Strategy for Vol CT]]
-* [[Initial Target Selection]] - describing the early prioritization discussions and settling on Lung Tumor Volumes
-*[[Media:2008.12.16.Sources_of_Variability_-_Andrew_Buckler.xls|Sources of Variability - Andrew Buckler]]
-==Reference Materials==
+'''2011'''
 *Dr Petrick's 2011 SPIE Presentation Materials
 *[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
 *[[Media:Spie2011 NP QIBA1A-Paper-v08-final-2.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Paper]]
+*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
+'''2010'''
+*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
+*[[Media:Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
+==Reference Articles==
 *Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. [http://www.academicradiology.org/issues/contents?issue_key=S1076-6332(09)X0002-4 Academic Radiology]
 * [http://radiology.rsnajnls.org/cgi/content/full/243/2/527#T2 Radiology 2007 - Coronary Calcium Scoring] - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses  similar issues (e.g. achieving "standard" noise levels).  It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
 *Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. [http://www.academicradiology.org/article/S1076-6332(08)00499-6/abstract Academic Radiology]
 *Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. [http://www.academicradiology.org/article/S1076-6332(08)00530-8/abstract Academic Radiology]
-*[[Media:QIBA CT-Volumetry as of 3-08-12.pdf|QIBA CT-Volumetry Technical Committee Roster as of 20120308]]
+*[[Archive - Initial Target Selection and Roadmap]]
-==Round 1 of QIBA Funded Projects==
+==QIBA Funded Projects==
-*[[TBN]]
+'''Round 1'''
 *[[Duke University]]
 *[[Columbia University Medical Center]]
 *[[University of Colorado Denver, Department of Radiology]]
 *[[David Geffen School of Medicine at UCLA, Department of Radiology]]
+*[[CoreLab Partners, Inc.]]
+'''Round 2'''
+*[[CoreLab Partners, Inc., Round-2]]
+*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
-==Round 2 of QIBA Funded Projects==
+'''Round 3'''
+*[[Media:Second 3A Statistical and Image Processing Analysis.pdf| Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
-*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
+'''Round 4'''
+*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf| Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
+*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf| Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
+'''Round 5'''
+*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf| Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
+'''Round 6'''
+*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf| Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]